1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 18 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Escherichia coli 83972 expressing a P fimbriae oligosaccharide receptor mimic impairs adhesion of uropathogenic E. coliWatts, R.; Tan, C.; Ulett, G.; Carey, A.; Totsika, M.; Idris, A.; Paton, A.; Morona, R.; Paton, J.; Schembri, M.
2003Mutation of luxS of Streptococcus pneumoniae affects virulence in a mouse modelStroeher, U.; Paton, A.; Ogunniyi, A.; Paton, J.
2010Tissue factor-dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coliWang, H.; Paton, J.; Thorpe, C.; Bonder, C.; Sun, W.; Paton, A.
2009Therapeutic strategies for Shiga toxin-producing Escherichia coli infectionsRogers, T.; Paton, A.
2009Sab, a novel autotransporter of locus of enterocyte effacement-negative shiga-toxigenic escherichia coli O113:H21, Contributes to adherence and biofilm formationHerold, S.; Paton, J.; Paton, A.
2012The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signalingRay, R.; de Ridder, G.; Eu, J.; Paton, A.; Paton, J.; Pizzo, S.
2012Limitation of individual folding resources in the ER leads to outcomes distinct from the unfolded protein responseEletto, D.; Maganty, A.; Eletto, D.; Dersh, D.; Makarewich, C.; Biswas, C.; Paton, J.; Paton, A.; Doroudgar, S.; Glembotski, C.; Argon, Y.
2009Suppression of NF-kappa B by Cyclosporin A and Tacrolimus (FK506) via Induction of the C/EBP Family: Implication for Unfolded Protein ResponseDu, S.; Hiramatsu, N.; Hayakawa, K.; Kasai, A.; Okamura, M.; Huang, T.; Yao, J.; Takeda, M.; Araki, I.; Sawada, N.; Paton, A.; Paton, J.; Kitamura, M.
2004Refinement of a therapeutic Shiga toxin-binding probiotic for human trialsPinyon, R.; Paton, J.; Paton, A.; Botten, J.; Morona, R.
2015Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatmentAdomako, A.; Calvo, V.; Biran, N.; Osman, K.; Chari, A.; Paton, J.; Paton, A.; Moore, K.; Schewe, D.; Aguirre-Ghiso, J.

Discover